Subject: NCI Bid Board Posting – Service Agreement for Incucyte S3 LiveService Agreement • November 22nd, 2022
At the National Cancer Institute (NCI), the Genitourinary Malignancies Branch (GMB) focuses on investigating the biology of genitourinary cancers, developing new strategies for treating those cancers, and evaluating these new therapeutic approaches through science-driven clinical research. These clinical trials investigate novel approaches in immunotherapy, hormonal therapy, chemotherapy combinations, and small-molecule targeted therapy.